Excited to share that ieumBio has been selected for the 2026 Seoul–Basel Startup Hub Acceleration Program.

This opportunity marks an important step in expanding our pathway into the Swiss and European longevity ecosystem.

At ieumBio, we are building KilliSpan™, a rapid vertebrate longevity evaluation platform designed to accelerate the discovery and validation of healthy aging interventions.

We look forward to connecting with global partners, innovators, and investors advancing the future of longevity and healthspan science.

#Longevity #Biotech #Healthspan #SwissBiotech #Basel #HealthyAging #DrugDiscovery #Startup #ieumBio